Victory Capital Management Inc Otonomy, Inc. Transaction History

Victory Capital Management Inc

  • $95.8 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020
SELL
$1.87 - $3.84 $7,977 - $16,381
-4,266 Closed
0 $0
Q1 2020

May 04, 2020
BUY
$1.58 - $4.06 $199 - $511
126 Added 3.04%
4,266 $8,000
Q4 2019

Feb 04, 2020
SELL
$2.13 - $3.83 $29 - $53
-14 Reduced 0.34%
4,140 $13,000
Q3 2019

Nov 12, 2019
BUY
$2.12 - $2.86 $8,806 - $11,880
4,154 New
4,154 $10,000

About OTONOMY, INC.

OTIC Quotes by TradingView
  • Ticker OTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,990,400
  • Description
  • Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...
More about OTIC
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email